Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Neuropeptides

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 8923511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antinociceptive effect of chronic nicotine and nociceptive effect of its withdrawal measured by hot-plate and tail-flick in rats

  2005cited by this paper
• Long-term stimulation of nicotinic receptors is required to increase proenkephalin A mRNA levels and the delayed secretion of [Met5]-enkephalin in bovine adrenal medullary chromaffin cells.

  1995cited by this paper
• Effects of intraventricular injection of morphine and beta-endorphin on serotonin release from the spinal cord in rats.

  1994cited by this paper
• Nicotine-induced antinociception in mice: role of G-proteins and adenylate cyclase.

  1994cited by this paper
• Plasma nicotine, plasma β-endorphin and mood states during periods of chronic smoking, abstinence and nicotine replacement

  1994cited by this paper
• The effects of protection by D-Pen2-D-Pen5-enkephalin or D-Ala2-NMePhe4-Gly-ol-enkephalin against beta-chlornaltrexamine in the spinal cord on the antinociception induced by beta-endorphin administered intracerebroventricularly in the mouse.

  1994cited by this paper
• Nicotine-induced analgesia in rats: the role of calcium and the diversity of responders and nonresponders.

  1993cited by this paper
• Intrathecal cholecystokinin octapeptide attenuates the antinociception and release of immunoreactive Met-enkephalin induced by intraventricular beta-endorphin in the rat.

  1992cited by this paper
• Opioid and nicotinic analgesic and hyperalgesic loci in the rat brain stem.

  1992cited by this paper
• Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular beta-endorphin-induced tail-flick inhibition in the mouse.

  1992cited by this paper
• Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.

  1992cited by this paper
• Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus.

  1991cited by this paper
• Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.

  1990cited by this paper
• Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain.

  1990cited by this paper
• Lack of antinociceptive cross-tolerance between intracerebroventricularly administered beta-endorphin and morphine or DPDPE in mice.

  1990cited by this paper
• Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.

  1990cited by this paper
• Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and β-endorphin in mice

  1990cited by this paper
• Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice.

  1989cited by this paper
• Intrathecal [Met5]enkephalin antibody blocks analgesia induced by intracerebroventricular beta-endorphin but not morphine in mice.

  1989cited by this paper
• Comparisons of descending pain inhibitory pathways activated by beta-endorphin and morphine as characterized by supraspinal and spinal antinociceptive interactions in mice.

  1988cited by this paper
• Opioid and nicotinic medullary hyperalgesic influences in the decerebrated rat.

  1988cited by this paper
• Beta-endorphin-(1-27) antagonizes beta-endorphin- but not morphine-, D-Pen2-D-Pen5-enkephalin- and U50, 488H-induced analgesia in mice.

  1988cited by this paper
• Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.

  1988cited by this paper
• Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways.

  1987cited by this paper
• Nicotine-induced alterations in brain regional concentrations of native and cryptic Met- and Leu-enkephalin.

  1987cited by this paper
• Release of immunoreactive met-enkephalin by intraventricular beta-endorphin in anesthetized rats.

  1986cited by this paper
• The spinal cord as a major site for the antinociceptive action of nicotine in the rat.

  1986cited by this paper
• Release of immunoreactive Met-enkephalin from the spinal cord by intraventricular beta-endorphin but not morphine in anesthetized rats.

  1985cited by this paper
• Nicotinic receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cells

  1984cited by this paper
• Separate involvement of the spinal noradrenergic and serotonergic systems in morphine analgesia: the differences in mechanical and thermal algesic tests.

  1983cited by this paper
• Antinociceptive action of nicotine and its methiodide derivatives in mice and rats

  1983cited by this paper
• Noradrenaline regulation of pain-transmission in the spinal cord mediated by alpha-adrenoceptors.

  1979cited by this paper
• Antinociceptive effects of central and systemic administrations of nicotine in the rat

  1979cited by this paper
• Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray.

  1979cited by this paper
• Microinjection of opioids into the nucleus reticularis gigantocellularis of the rat: analgesia and increase in the normetanephrine level in the spinal cord.

  1978cited by this paper
• Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

  1957cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Ameliorative effects of varenicline and bupropion on morphine-induced conditioned place preference in rats

  2022cites this paper
• Dopamine receptors in the anterior cingulate cortex implicate in nicotine enhanced morphine analgesia

  2021cites this paper
• Antinociceptive effect of tebanicline for various noxious stimuli-induced behaviours in mice.

  2017cites this paper
• The role of nicotinic acetylcholine receptors in motivated behaviour

  2016cites this paper
• A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation.

  2012cites this paper
• Blocking α4β2 and α7 nicotinic acetylcholine receptors inhibits the reinstatement of morphine-induced CPP by drug priming in mice.

  2011cites this paper
• The analgesic and toxic effects of nornicotine enantiomers alone and in interaction with morphine in rodent models of acute and persistent pain.

  2010cites this paper
• Smoking and Pain: Pathophysiology and Clinical Implications

  2010cites this paper
• Modulation of alcohol and nicotine responses through the endogenous opioid system.

  2010cites this paper
• Pathophysiology and Clinical Implications

  2010cites this paper
• Effects of chronic nicotine on behavioural and neurochemical responses to morphine

  2009cites this paper
• Involvement of kappa/dynorphin system in the development of tolerance to nicotine‐induced antinociception

  2008cites this paper
• Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA

  2008cites this paper
• The effect of formalin pretreatment on nicotine-induced antinociceptive effect: the role of mu-opioid receptor in the hippocampus.

  2008cites this paper
• Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.

  2006cites this paper
• Effects of ultra-low doses of nicotine on the expression of morphine-induced conditioned place preference in mice

  2006cites this paper
• Mu‐opioid receptors are involved in the tolerance to nicotine antinociception

  2006cites this paper
• The Role of Adrenergic and Cholinergic Transmission in Volatile Anesthetic-Induced Pain Enhancement

  2005cites this paper
• Nicotine-Induced Antinociception, Rewarding Effects, and Physical Dependence Are Decreased in Mice Lacking the Preproenkephalin Gene

  2005cites this paper
• The κ-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety

  2005cites this paper
• The Heritability of Antinociception: Common Pharmacogenetic Mediation of Five Neurochemically Distinct Analgesics

  2003cites this paper
• m REVIEW ARTICLE

  2001cites this paper
• Gene Therapy for the Management of Pain: Part II: Molecular Targets

  2001cites this paper
• Nicotinic Receptors in the Nervous System

  2001cites this paper
• Nicotinic Cholinergic Receptors as Targets in Pain Control

  2001cites this paper
• Nicotinic Receptors in the Brain: Links between Molecular Biology and Behavior

  2000cites this paper
• The promise and pitfalls of a nicotinic cholinergic approach to pain management.

  2000cites this paper
• PII: S0304-3959(00)00389-4

  2000cites this paper
• Clinical Aspects of Nicotinic Agents: Therapeutic Applications in Central Nervous System Disorders

  2000cites this paper
• Physiological changes in Pachinko players; beta-endorphin, catecholamines, immune system substances and heart rate.

  1999cites this paper